The independent source for health policy research, polling, and news.
161-180 of 238 results
A new study from the University of California-Davis shows a significant increase in five-year survival rates for more than 20 types of cancer, but with significant disparities by race, ethnicity and economic status. That is in line with the national trend.
A new study of 6,000 older patients shows little gain from surgeries for breast cancer.
The six-term Arizona senator, who died Saturday, took on some of health care’s goliaths, such as the tobacco industry and insurance companies, in addition to the health law.
Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.
The American Society of Clinical Oncology issued a new guideline that recommends adults 65 and older receive a geriatric assessment when considering or undergoing chemotherapy.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
KHN senior correspondent Liz Szabo joins a panel on WAMU's radio show "1A" to discuss new insight into breast cancer treatment.
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says that the listing is unjustified and that science is on its side.
Advertising for hospitals, unlike pharmaceutical companies, doesn't have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
© 2026 KFF